Addition Therapeutics Competitors: 10 Similar Biotech

Addition Therapeutics — investors and similar companies (54)

Companies comparable to Addition Therapeutics in Biotech, headquartered in South San Francisco, CA, ranked by how much of Addition Therapeutics's verified investor base they share. 88 of the companies below have at least one backer in common with Addition Therapeutics.

Overlap is computed from disclosed round records rather than from sector labels, so a company appears here because the same firms wrote cheques into both — the signal a founder benchmarking comparables or an investor mapping a sector actually wants. Each entry links to that company's own funding record and syndicate breakdown.

• Verified backers on record: 6
• Total disclosed funding: $100M
• Latest tracked round: null (2025-12-17)
• Sector: Biotech
• Headquarters: South San Francisco, CA

• SR One
• Pivotal Life Sciences
• Abingworth
• Osage University Partners
• the Gates Foundation
• BEVC
• Vaxcyte — shares Abingworth
• GenSight Biologics — shares Abingworth
• Chiasma — shares Abingworth
• ENYO Pharma — shares SR One
• R1 Therapeutics — shares Abingworth
• Opsys Tech — shares Osage University Partners
• SiFive — shares Osage University Partners
• Aristea Therapeutics — shares SR One
• Selecta Biosciences — shares Osage University Partners
• OncXerna Therapeutics — shares Osage University Partners
• Personalis — shares Abingworth
• Venatorx Pharmaceuticals, Inc. — shares Abingworth
• ReCode Therapeutics — shares Osage University Partners
• Attralus — shares Abingworth
• Palleon Pharmaceuticals — shares SR One
• Reneo Pharmaceuticals — shares Abingworth
• Ascend Gene & Cell Therapies — shares Abingworth
• Fortis Therapeutics — shares Osage University Partners
• Kymeta — shares Osage University Partners
• Windward Bio — shares SR One
• Cyteir Therapeutics — shares Osage University Partners
• Antag Therapeutics — shares SR One
• Arkuda Therapeutics — shares Pivotal Life Sciences
• Alphina Therapeutics — shares Osage University Partners
• Avenzo Therapeutics — shares SR One
• Pairwise Plants — shares Osage University Partners
• Aptinyx — shares Osage University Partners
• Quantum Circuits — shares Osage University Partners
• Q32 Bio — shares Osage University Partners +1
• StreetLight Data — shares Osage University Partners
• Nkarta Therapeutics — shares SR One
• cAMPfield Therapeutics — shares Abingworth
• Ascend Advanced Therapies — shares Abingworth
• Cytospire Therapeutics — shares Abingworth
• Ancora Biotech LLC — shares SR One
• Avila Therapeutics — shares Abingworth
• Decibel Therapeutics — shares SR One
• MicroTransponder — shares Osage University Partners
• MISSION Therapeutics — shares SR One
• CHARM Therapeutics — shares SR One
• Anjarium Biosciences — shares Abingworth
• Morphic Therapeutic — shares SR One
• Effector Therapeutics — shares Abingworth +1
• Design Therapeutics — shares SR One
• Nido Biosciences — shares Abingworth +1
• Pionyr Immunotherapeutics — shares Osage University Partners
• IFM Therapeutics — shares Abingworth
• Nimbus Therapeutics — shares SR One

Addition Therapeutics funding profile · All research reports